Matrix Laboratories Limited

21 articles about Matrix Laboratories Limited

• 

  Top 5 Women Executives in the Biopharma Industry by Compensation

  6/26/2018

  Not only are women generally underrepresented in the biopharma industry, but compared to many of the top male executives, underpaid. Here’s a closer look at the top five female executives by pay in the biopharma industry.

• Matrix Laboratories Limited Completes Name Change to Mylan Laboratories Inc.

  10/19/2011

• Mylan Inc.'s Matrix Laboratories Limited Gets Tentative FDA Approval for AIDS Drug

  9/21/2011

• Mylan Inc.'s Matrix Laboratories Limited Receives Approval for Generic Version of Aricept(R) Tablets

  6/7/2011

• Mylan Inc. to Rebrand Matrix Laboratories Limited

  5/27/2011

• Mylan Inc.'s Matrix Laboratories Limited Receives FDA Approval Under PEPFAR for Zidovudine Tablets, 100 mg

  3/10/2011

• Mylan Inc.'s Matrix Laboratories Limited Receives Approval for Generic Version of Neurontin(R) Capsules

  2/28/2011

• Tibotec Pharmaceuticals Ltd Signs Multiple Agreements With Generic Manufacturers, Including Mylan Inc.'s Matrix Laboratories Limited, Aspen Pharmacare Holdings and Hetero Drugs to Provide Access to New HIV Treatment

  1/27/2011

• Another Gastroesophageal Reflux Disease Drug Goes Generic by Matrix Laboratories Limited

  1/26/2011

• Mylan Inc.'s Matrix Laboratories Limited Receives Tentative FDA Approval Under PEPFAR for Lamivudine and Zidovudine Tablets, 30 mg/60 mg

  1/20/2011

• Mylan Inc. Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories Limited' New Drug Application (NDA) for Efavirenz Tablets

  12/22/2009

• Mylan Inc. Receives FDA Approval for Generic Version of Prevacid(R) Through its Subsidiary Matrix Laboratories Limited

  11/11/2009

• Mylan Inc. to Pay $133 Million for Rest of Matrix Laboratories Limited

  3/27/2009

• Mylan Inc.'s Matrix Laboratories Limited Receives World Health Organization Approval for First Generic, Heat-Stable Version of HIV Protease Inhibitor

  2/25/2009

• Matrix Laboratories Limited May Sell European Generics Unit Docpharma

  2/28/2008

• Mylan Laboratories Inc. Completes Matrix Laboratories Limited Transaction

  1/9/2007

• Mylan Laboratories Inc. Announces Closing Of Public Offer To Acquire 20% Of Matrix Laboratories Limited

  12/21/2006

• Gilead Sciences (Foster City, CA) Announces Licensing Agreements With Eight India-Based Companies For Manufacturing And Distribution Of Generic Versions Of Viread In The Developing World

  9/25/2006

• The Day In Review: FDA Pays $500 Million For Cancer Drug

  8/28/2006

• Mylan Laboratories Inc. To Acquire Matrix Laboratories Limited For Up To $736 Million

  8/28/2006